Legal attitude: Art. 17 para. 1 MAR - confidential information.
Board of MPL VERBUM S.A. informs that the subsidiary ENforce Medical Technologies Sp. z o.o. with share capital of PLN 5,000.00, in which 80% of branches belong to MPL VERBUM S.A. signed with the Office of the Wielkopolska Region, a contract for co-financing of the project entitled "Strengthening the innovative potential of ENforce Medical Technologies Ltd. by investing in research and development infrastructure and conducting research to develop a prototype bionic foot prosthesis" under Priority Axis 1 "Innovative and competitive economy" Measures 1.2 "Strengthening the innovative potential of Wielkopolska enterprises" of Wielkopolska Regional Operational Program for the years 2014 - 2020. The total value of the project is: PLN 1,624.357,40, and the amount of funding will be PLN 1,196.486,40.
At the same time, the Management Board of MPL VERBUM S.A. informs about signing between MPL VERBUM S.A. and ENforce Medical Technologies Sp. z o.o. a loan agreement for the amount of PLN 300,000.00, for a period of three years, which will be entirely allocated to cover own contribution in the aforementioned project.
ENforce Medical Technologies Sp. z o.o. is a research company that specializes in providing new technologies in the field of biomedical engineering. The company has an interdisciplinary team specializing in construction, automation, biomechanics and telemedicine, as well as in rapid prototyping technologies. The combination of these areas is a guarantee of success in modern projects in the medical industry. The company plans to establish cooperation with the Poznań University of Technology and the Medical University in Poznań. Within its framework, the Company will prepare an offer of services in the field of research and development in the field of broadly understood biomedical engineering.
After the implementation of the project co-financed by ENforce Medical Technologies Sp. z o.o. it would have a ready for implementation project of the first bionic prosthesis in Poland. Its technical and functional parameters will allow it to compete with the most modern constructions of global manufacturers, while maintaining the price at the level of prices of competing products, offering only basic parameters. The project is a response to the medical market's demand for modern products / technologies that can meet the needs of large quantitiesusers (annually in Poland, almost 13,000 people after amputations of lower limbs) and barriers to their functioning in the private and professional area.
The partners of the ENforce Medical Technologies Sp. z o.o. they plan that in the perspective of 2020-2021, the Company will commercialize both the developed prosthesis and the innovative technologies developed during its creation.
Source: company website, investor relations, current and periodic reports.